申请人:Shionogi & Co., Ltd.
公开号:US20170209454A1
公开(公告)日:2017-07-27
The present invention is to provide a novel compound (I) shown below, having the anti-virus activity; particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug, as well as a process and an intermediate thereof.
(wherein
Z
1
is NR
4
;
R
1
is hydrogen or lower alkyl;
X is a single bond, a hetero atom group selected from O, S, SO, SO
2
and NH, or lower alkylene or lower alkenylene in which the hetero atom group may intervene;
R
2
is optionally substituted aryl;
R
3
is hydrogen, a halogen, hydroxy, optionally substituted lower alkyl etc; and
R
4
and Z
2
part taken together forms a ring, to form a polycyclic compound, including e.g., a tricyclic or tetracyclic compound.